I-Cancer-Ibrutinib Intermediates

3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 330786-24-8

Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial Pharmaceutical |Izidakamizwa ze-Antitumor |Ibrutinib Intermediates |3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |CAS:330786-24-8 |I-C17H13N5O

uphenyo imininingwane
3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole 330792-70-6

Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial Pharmaceutical |Izidakamizwa ze-Antitumor |Ibrutinib Intermediates |3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole |I-CAS: 330792-70-6|I-C16H12N4O

uphenyo imininingwane
I-1-Boc-3-hydroxypiperidine 85275-45-2

Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial Pharmaceutical |Izidakamizwa ze-Antitumor |Ibrutinib Intermediates |1-Boc-3-hydroxypiperidine |CAS:85275-45-2 |I-C10H19NO3

uphenyo imininingwane
(S)-1-Boc-3-hydroxypiperidine 143900-44-1

Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial Pharmaceutical |Izidakamizwa ze-Antitumor |Ibrutinib Intermediates |(S)-1-Boc-3-hydroxypiperidine |CAS:143900-44-1 |I-C10H19NO3

uphenyo imininingwane